Immix Biopharma Announces Dr. Vaishali Sanchorawala, AL Amyloidosis Thought Leader, Director of the Amyloidosis Center at Boston University and Boston Medical Center, Joins Scientific Advisory Board

Dr. Sanchorawala co-authored landmark study of daratumumab in AL Amyloidosis published in The New England Journal of Medicine, 2021 that led to it becoming a first-line standard of careLOS ANGELES,...

Related Keywords

Boston University ,Massachusetts ,United States ,Boston University Medical Center ,Boston ,Vaishali Sanchorawala ,Mike Moyer ,Gabriel Morris ,Ilya Rachman ,International Society Of Amyloidosis ,Immix Biopharma Inc ,Amyloidosis Center At Boston Medical ,Company Contact ,Skinner Professor Of Amyloidosis Research ,Steering Committee Of Amyloidosis Research Consortium ,Rutgers Health New Jersey Medical School ,Exchange Commission ,Nasdaq ,New England Journal ,Nexcella Scientific Advisory ,Chief Executive Officer ,Chief Financial Officer ,Immix Biopharma ,Skinner Professor ,Amyloidosis Research ,Boston University Chobanian ,Avedisian School ,Amyloidosis Center ,Boston Medical Center ,Associate Editor ,Protein Folding Disorders ,International Society ,Executive Steering Committee ,New Jersey Medical School ,Boston University Medical ,Internal Medicine ,Orphan Drug Designation ,Rare Pediatric Disease Designation ,Risk Factor ,Annual Report ,Markets ,